Pharma Solutions
Overview
Cardio Metabolic
MASLD/MASH
Autoimmune Disease
Gastrointestinal Disease
Oncology
Clinical Solutions
LiverMultiScan
MRCP+
CoverScan
Hepatica
Perspectum Portal
Research
Overview
Publications
Research Projects
Research Network
company
Overview
Senior Management
Board of Directors
Company News
Careers
Events
Webinars
Media Center
OUR LOCATIONS
< RETURN TO RESEARCHERS
Publications
Atlas
CoverScan
Digipath
Hepatica
LiverMultiScan
MRCP+
Pathology Solutions
Pharma Solutions
AILD
Autoimmun hepatitits (AIH)
Autoimmune liver disease (AILD)
Autoimmune sclerosis cholangitis (ASC)
Biliary disease
COVID-19
Cardiac lipid accumulation
Cholestatic liver disease
Chronic liver disease
Colorectal liver metastases
Diastolic dysfunction
Diffuse liver disease
Focal liver disease
Genetic sequencing
Haemochromatosis
Hemochromatosis
Hepatic steatosis
Hepatitis C virus (HCV)
Hepatobiliary disease
Hepatocellular carcinoma (HCC)
Iron overload
LV hypertrophy
Liver cancer
Long COVID
Muti-organ impairment
Myocardial steatosis
NAFLD/NASH
Pancreatic cancer
Pancreatic fat
Pancreatitis
Portal hypertension
Primary biliary cholangitis (PBC)
Primary sclerosing cholangitis (PSC)
SARS-COV2
Type 2 diabetes (T2DM)
UK Biobank
Wilson disease
Filter by disease type
Any
Filter by product
Any
Search:
placeholder
clear filter
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Non-invasive assessment of liver disease in rats using multiparametric magnetic resonance imaging: a feasibility study
Author:
Anna M. Hoy, Natasha McDonald, Ross J. Lennen, Matteo Milanesi, Amy H. Herlihy, Timothy J. Kendall, William Mungall, Michael Gyngell, Rajarshi Banerjee, Robert L. Janiczek, Philip S. Murphy, Maurits A. Jansen, Jonathan A. Fallowfield
Journal:
Biology Open
Publication Year:
2018
Volume/Issue:
7
Pages:
Multiparametric magnetic resonance imaging for quantitation of liver disease: a two-centre cross-sectional observational study
Author:
McDonald N, Eddowes PJ, Hodson J, Semple SIK, Davies NP, Kelly CJ, Kin S, Phillips M, Herlihy AH, Kendall TJ, Brown RM, Neil DAH, Hübscher SG, Hirschfield GM, Fallowfield JA.
Journal:
Scientific Reports
Publication Year:
2018
Volume/Issue:
8
Pages:
Article 9189
Study protocol: HepaT1ca – an observational clinical cohort study to quantify liver health in surgical candidates for liver malignancies
Author:
Mole, D. J., Fallowfield, J. A., Kendall, T. J., Welsh, F., Semple, S. I., Bachtiar, V., Kelly, M., Wigmore, S. J., James Garden, O., Wilman, H. R., Banerjee, R., Rees, M., & Brady, M.
Journal:
BMC Cancer
Publication Year:
2018
Volume/Issue:
18(1)
Pages:
890
Utility and variability of three non-invasive liver fibrosis imaging modalities to evaluate efficacy of GR-MD-02 in subjects with NASH and bridging fibrosis during a phase-2 randomized clinical trial
Author:
Harrison, S. A., Dennis, A., Fiore, M. M., Kelly, M. D., Kelly, C. J., Paredes, A. H., Whitehead, J. M., Neubauer, S., Traber, P. G., & Banerjee, R.
Journal:
PLOS ONE
Publication Year:
2018
Volume/Issue:
13(9)
Pages:
e0203054
1
...
11 / 27
Digipath
Atlas
Pharma Solutions
CoverScan
Hepatica
LiverMultiScan
Pathology Solutions
MRCP+
UK Biobank
Pancreatitis
Pancreatic cancer
Wilson disease
Cardiac lipid accumulation
Diastolic dysfunction
LV hypertrophy
Myocardial steatosis
Portal hypertension
Iron overload
Haemochromatosis
Hemochromatosis
Hepatobiliary disease
Primary biliary cholangitis (PBC)
Type 2 diabetes (T2DM)
Diffuse liver disease
Cholestatic liver disease
Hepatitis C virus (HCV)
SARS-COV2
Long COVID
Pancreatic fat
Muti-organ impairment
COVID-19
Hepatic steatosis
Chronic liver disease
Hepatocellular carcinoma (HCC)
Colorectal liver metastases
Focal liver disease
Liver cancer
Primary sclerosing cholangitis (PSC)
Biliary disease
Genetic sequencing
NAFLD/NASH
Autoimmune sclerosis cholangitis (ASC)
Autoimmune liver disease (AILD)
Autoimmun hepatitits (AIH)
AILD